NRT improves quitting success rates and reduces cessation-induced weight gain. It’s a fact; and there are a lot of anti-addictive pharmacological interventions that do too.
Dear obesity researchers, primary care physicians, and smokers,
Rimonabant is the anti-“munchies” drug that blocks the marijuana receptor CB1. It causes weight loss. But 20 mg daily also increases the odds of successfully quitting smoking by 50 – 60% (Cahill and Ussher, 2007).
Marijuana: not really addictive.
Obesity diets: delicious, but not really addictive.
Cigarettes: definitely addictive.
Rimonabant: anti-addictive. It causes weight loss in overweight but not lean people, perhaps because lean people don’t eat obesity diets (?).
Or more specifically, caffeine and nicotine… or really just nicotine. Today is about the lesser of two evils: nicotine, Mother Nature’s little helper (the other evil being cigarettes [not coffee]). This curious little molecule is an anti-inflammatory memory boosting appetite suppressant. If it didn’t screw with the reward mechanisms in your brain, it’d be a vitamin. Part 1. Cigarettes, nicotine, and metabolic function Exhibit A: Activation of the cholinergic anti-inflammatory pathway ameliorates obesity-induced inflammation and insulin resistance (Wang et al., 2011) translation: “nicotine is good for mice.” Continue reading
I’m not pro-big tobacco or cigarettes, but I am anti-scare tactics. It is usually the news media or politicians, exaggerating and/or grossly misinterpreting some study findings in order to make a great headline or secure votes. But in this case, it wasn’t. The predators who were preying on our fear were the scientists. Smokers of the world, unite!
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws (Hurt et al., 2012)